Biological factors influencing parathyroid localization

Nuclear Medicine Communications

Volumn 24, Issue 2, 2003, Pages 121-124

  Pons, F ^a   Torregrosa, J V ^a   Fuster, D ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Hyperparathyroidism; P glycoprotein; Parathyroid glands; Parathyroid scintigraphy

Indexed keywords

BIOLOGICAL FACTOR; DIAGNOSTIC AGENT; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MULTIDRUG RESISTANCE PROTEIN; PARATHYROID HORMONE; RADIOPHARMACEUTICAL AGENT;

DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERPARATHYROIDISM; LABORATORY DIAGNOSIS; METABOLISM; MITOCHONDRION; REVIEW; SCINTISCANNING;

BIOLOGICAL FACTORS; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; HUMANS; HYPERPARATHYROIDISM; MITOCHONDRIA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PARATHYROID HORMONE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 85047278462     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200302000-00003     Document Type: Article

References (20)

1. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H. Histopathology, pathophysiology and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997; 13: 78-86.
2. Fugakawa M, Kitaoka M, Yi H, et al. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 1994; 68: 221-228.
3. Pons F, Torregrosa JV, Vidal-Sicart S, et al. Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperparathyroidism. Eur J Nucl Med 1997; 24: 1494-1498.
4. Torregrosa JV, Palomar MR, Pons F, et al. Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism? Nephrol Dial Transplant 1998; 13: 37-40.
5. 99mTc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg 2000; 24: 1386-1390.
6. Carpentier A, Jeannotte S, Verreault J, et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 1998; 39: 1441-1444.
7. Ishibashi M, Nishida H, Okuda S, Suekane S, Hayabuchi N. Localization of parathyroid glands in hemodialysis patients using Tc-99m sestamibi imaging. Nephron 1998; 78: 48-53.
8. Pinero A, Rodriguez JM, Ortiz S, et al. Relation of biochemical, cytologic, and morphologic parameters to the result of gammagraphy with technetium 99m sestamibi in primary hyperparathyroidism. Otolaryngol Head Neck Surg 2000; 122: 851-855.
9. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis-(2-methoxyisobutylisonitrile) technetium in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-1653.
10. Hetrakul N, Civeleck AC, Stagg CA, Udelsman R. in vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria. Surgery 2001; 130: 1011-1018.
11. Ambrosoni P, Heuguerot C, Olaizola I, et al. Can we use 99mTc-MIBI in functional studies of the parathyroid gland? Nephrol Dial Transplant 1998; 13(suppl 3): 33-36.
12. McCarron DA, Muther RS, Lenfesty B, Bennett WM. Parathyroid function in persistent hyperparthyroidism: relationship to gland size. Kidney Int 1982; 22: 662-670.
13. Piga M, Bolasco P, Satta L, et al. Double-phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med 1996; 37: 565-569.
14. 99mTc-sestamibi scintigraphy in chronic hemodialysis patients: correlation with biochemical markers of parathyroid function. Nucl Med Commun 2002; 24: 85-90.
15. Wu HS, Liu YC, Kao A, Wang JJ, Ho ST. Technetium 99m tetrofosmin parathyroid imaging to detect parathyroid adenoma and its relation to P-glycoprotein expression. Surgery 2002; 132: 456-460.
16. Kao A, Shiau YC, Tsai SC, Wang JJ, Ho ST. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression. Eur J Nucl Med 2002; 29: 1012-1015.
17. Yamaguchi S, Yachiku S, Hashimoto H, et al. Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands. World J Surg 2002; 26: 29-34.
18. Bhatnagar A, Vezza PR, Bryan JA, Atkins FB, Ziessman HA. Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability. J Nucl Med 1998; 39: 1617-1620.
19. Shiau YC, Tsai SC, Wang JJ, Ho ST, Kao A. Detecting parathyroid adenoma using technetium-99m tetrofosmin: comparison with P-glycoprotein and multidrug resistance related protein expression - a preliminary report. Nucl Med Biol 2002; 29: 339-344.
20. 99mTc-tetrofosmin uptake in parathyroid adenomas. Nucl Med Commun 2002; 23: 1001-1004.